Back to Browse Journals » Infection and Drug Resistance

Infection and Drug Resistance


Journal Articles:

- 237 records -

Assessing the oseltamivir-induced resistance risk and implications for influenza infection control strategies

Hsieh NH, Lin YJ, Yang YF, Liao CM

Infection and Drug Resistance 2017, 10:215-226

Published Date: 20 July 2017

Determinants of multidrug-resistant tuberculosis in Addis Ababa, Ethiopia

Assefa D, Seyoum B, Oljira L

Infection and Drug Resistance 2017, 10:209-213

Published Date: 11 July 2017

Genotyping of HBV and tracking of resistance mutations in treatment-naïve patients with chronic hepatitis B

Pacheco SR, Santos MIMA, Stocker A, Zarife MAS, Schinoni MI, Paraná R, Reis MG, Silva LK

Infection and Drug Resistance 2017, 10:201-207

Published Date: 5 July 2017

Incomplete recovery of the fecal flora of hematological patients with neutropenia and repeated fluoroquinolone prophylaxis

Chong Y, Shimoda S, Miyake N, Aoki T, Ito Y, Kamimura T, Shimono N

Infection and Drug Resistance 2017, 10:193-199

Published Date: 27 June 2017

Rifampicin-resistant Mycobacterium tuberculosis among tuberculosis-presumptive cases at University of Gondar Hospital, northwest Ethiopia

Jaleta KN, Gizachew M, Gelaw B, Tesfa H, Getaneh A, Biadgo B

Infection and Drug Resistance 2017, 10:185-192

Published Date: 14 June 2017

Prevalence and antibiotic resistance of coagulase-negative Staphylococci isolated from poultry farms in three regions of Ghana

Boamah VE, Agyare C, Odoi H, Adu F, Gbedema SY, Dalsgaard A

Infection and Drug Resistance 2017, 10:175-183

Published Date: 13 June 2017

Genotypic distribution of multidrug-resistant and extensively drug-resistant tuberculosis in northern Thailand

Jaksuwan R, Tharavichikul P, Patumanond J, Chuchottaworn C, Chanwong S, Smithtikarn S, Settakorn J

Infection and Drug Resistance 2017, 10:167-174

Published Date: 10 June 2017

Microbiome disruption and recovery in the fish Gambusia affinis following exposure to broad-spectrum antibiotic

Carlson JM, Leonard AB, Hyde ER, Petrosino JF, Primm TP

Infection and Drug Resistance 2017, 10:143-154

Published Date: 9 May 2017

Uniform-related infection control practices of dental students

Aljohani Y, Almutadares M, Alfaifi K, El Madhoun M, Albahiti MH, Al-Hazmi N

Infection and Drug Resistance 2017, 10:135-142

Published Date: 24 April 2017

Drug resistance in influenza A virus: the epidemiology and management

Hussain M, Galvin HD, Haw TY, Nutsford AN, Husain M

Infection and Drug Resistance 2017, 10:121-134

Published Date: 20 April 2017

In situ detection of Chlamydia pneumoniae, C. trachomatis, and cytokines among cardiovascular diseased patients from the Amazon region of Brazil

Freitas LS, Almeida NCC, Freitas Queiroz MA, Zaninotto MM, Fuzii HT, Ribeiro-Silva A, Vallinoto ACR, Ishak MOG, Quaresma JAS, Ishak R

Infection and Drug Resistance 2017, 10:109-114

Published Date: 10 April 2017

The "black evil" affecting patients with diabetes: a case of rhino orbito cerebral mucormycosis causing Garcin syndrome

Narayanan S, Panarkandy G, Subramaniam G, Radhakrishnan C, Thulaseedharan NK, Manikath N, Ramaswamy S, Radhakrishnan S, Ekkalayil D

Infection and Drug Resistance 2017, 10:103-108

Published Date: 28 March 2017

Risk factors for multidrug-resistant tuberculosis among tuberculosis patients: a case-control study

Workicho A, Kassahun W, Alemseged F

Infection and Drug Resistance 2017, 10:91-96

Published Date: 13 March 2017

Antibiotic resistance among Helicobacter pylori clinical isolates in Lima, Peru

Boehnke KF, Valdivieso M, Bussalleu A, Sexton R, Thompson KC, Osorio S, Novoa Reyes I, Crowley JJ, Baker LH, Xi C

Infection and Drug Resistance 2017, 10:85-90

Published Date: 10 March 2017

Effect of a small molecule Lipid II binder on bacterial cell wall stress

Malin J, Shetty AC, Daugherty SC, de Leeuw EPH

Infection and Drug Resistance 2017, 10:69-73

Published Date: 28 February 2017

Post-influenza aspergillosis, do not underestimate influenza B

Nulens EF, Bourgeois MJ, Reynders MB

Infection and Drug Resistance 2017, 10:61-67

Published Date: 21 February 2017

Cerebral malaria: insight into pathogenesis, complications and molecular biomarkers

Yusuf FH, Hafiz MY, Shoaib M, Ahmed SA

Infection and Drug Resistance 2017, 10:57-59

Published Date: 2 February 2017

Burden of methicillin-resistant Staphylococcus aureus pneumonia among hospitalized patients in Lebanon and Saudi Arabia

Althaqafi AO, Matar MJ, Moghnieh R, Alothman AF, Alenazi TH, Farahat F, Corman S, Solem CT, Raghubir N, Macahilig C, Haider S, Stephens JM

Infection and Drug Resistance 2017, 10:49-55

Published Date: 2 February 2017

Treatment patterns, resource utilization, and outcomes among hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections in Lebanon and Saudi Arabia

Matar MJ, Moghnieh R, Alothman AF, Althaqafi AO, Alenazi TH, Farahat FM, Corman S, Solem CT, Raghubir N, Macahilig C, Haider S, Stephens JM

Infection and Drug Resistance 2017, 10:43-48

Published Date: 3 February 2017

Burden and treatment patterns of invasive fungal infections in hospitalized patients in the Middle East: real-world data from Saudi Arabia and Lebanon

Alothman AF, Althaqafi AO, Matar MJ, Moghnieh R, Alenazi TH, Farahat FM, Corman S, Solem CT, Raghubir N, Macahilig C, Charbonneau C, Stephens JM

Infection and Drug Resistance 2017, 10:35-41

Published Date: 2 February 2017

Extended-spectrum beta-lactamase- and carbapenemase-producing Enterobacteriaceae among Ethiopian children

Legese MH, Weldearegay GM, Asrat D

Infection and Drug Resistance 2017, 10:27-34

Published Date: 25 January 2017

Peptide consensus sequence determination for the enhancement of the antimicrobial activity and selectivity of antimicrobial peptides

Almaaytah A, Ajingi Y, Abualhaijaa A, Tarazi S, Alshar’i N, Al-Balas Q

Infection and Drug Resistance 2017, 10:1-17

Published Date: 29 December 2016

Availability, perceptions, and characteristics of antibiograms among Illinois pediatricians

Spiekerman KM, Patel SJ, Patel R, Kociolek LK

Infection and Drug Resistance 2016, 9:269-274

Published Date: 5 December 2016

Assessing parasite clearance during uncomplicated Plasmodium falciparum infection treated with artesunate monotherapy in Suriname

Vreden SGS, Bansie RD, Jitan JK, Adhin MR

Infection and Drug Resistance 2016, 9:261-267

Published Date: 24 November 2016

The pharmacokinetics of vancomycin during the initial loading dose in patients with septic shock

Katip W, Jaruratanasirikul S, Pattharachayakul S, Wongpoowarak W, Jitsurong A, Lucksiri A

Infection and Drug Resistance 2016, 9:253-260

Published Date: 22 November 2016

Evaluating vancomycin susceptibility in Staphylococcus aureus

Mimica MJ, Navarini A

Infection and Drug Resistance 2016, 9:239-241

Published Date: 26 September 2016

Aspergillus fumigatus in the cystic fibrosis lung: pros and cons of azole therapy

Burgel PR, Paugam A, Hubert D, Martin C

Infection and Drug Resistance 2016, 9:229-238

Published Date: 20 September 2016

Lemierre’s syndrome: current perspectives on diagnosis and management

Johannesen KM, Bodtger U

Infection and Drug Resistance 2016, 9:221-227

Published Date: 14 September 2016

Lyme disease: the promise of Big Data, companion diagnostics and precision medicine

Stricker RB, Johnson L

Infection and Drug Resistance 2016, 9:215-219

Published Date: 13 September 2016

Pelvic inflammatory disease: improving awareness, prevention, and treatment

Das BB, Ronda J, Trent M

Infection and Drug Resistance 2016, 9:191-197

Published Date: 19 August 2016

Emerging resistant serotypes of invasive Streptococcus pneumoniae

Elshafie S, Taj-Aldeen SJ

Infection and Drug Resistance 2016, 9:153-160

Published Date: 29 June 2016

Concern over Zika virus outbreak: another alarming global threat

Hafiz MY, Mahmood SU, Shoaib M, Yusuf FH

Infection and Drug Resistance 2016, 9:149-151

Published Date: 28 June 2016

Optimal management of genital herpes: current perspectives

Sauerbrei A

Infection and Drug Resistance 2016, 9:129-141

Published Date: 13 June 2016

Conceptual framework for outcomes research studies of hepatitis C: an analytical review

Sbarigia U, Denee TR, Turner NG, Wan GJ, Morrison A, Kaufman AS, Rice G, Dusheiko GM

Infection and Drug Resistance 2016, 9:101-117

Published Date: 27 May 2016

Isavuconazole in the treatment of invasive aspergillosis and mucormycosis infections

Donnelley MA, Zhu ES, Thompson GR 3rd

Infection and Drug Resistance 2016, 9:79-86

Published Date: 2 June 2016

Enzymatic degradation of in vitro Staphylococcus aureus biofilms supplemented with human plasma

Watters CM, Burton T, Kirui DK, Millenbaugh NJ

Infection and Drug Resistance 2016, 9:71-78

Published Date: 27 April 2016

Species-based comparison of disease severity and risk factors for disseminated Candida infections in pediatric patients

Hawkshead III JJ, Van Dyke RB, Hassig SE, Webber LS, Begue RE

Infection and Drug Resistance 2016, 9:59-70

Published Date: 18 April 2016

Daptomycin: an evidence-based review of its role in the treatment of Gram-positive infections

Gonzalez-Ruiz A, Seaton RA, Hamed K

Infection and Drug Resistance 2016, 9:47-58

Published Date: 15 April 2016

Methicillin-resistant Staphylococcus aureus multiple sites surveillance: a systemic review of the literature

Chipolombwe J, Török ME, Mbelle N, Nyasulu P

Infection and Drug Resistance 2016, 9:35-42

Published Date: 12 February 2016

Pseudomonas aeruginosa ventilator-associated pneumonia management

Ramírez-Estrada S, Borgatta B, Rello J

Infection and Drug Resistance 2016, 9:7-18

Published Date: 20 January 2016

Laboratory-based nationwide surveillance of antimicrobial resistance in Ghana

Opintan JA, Newman MJ, Arhin RE, Donkor ES, Gyansa-Lutterodt M, Mills-Pappoe W

Infection and Drug Resistance 2015, 8:379-389

Published Date: 18 November 2015

Delamanid expanded access novel treatment of drug resistant tuberculosis

Rustomjee R, Zumla A

Infection and Drug Resistance 2015, 8:359-366

Published Date: 29 October 2015

Clinical ineffectiveness of latamoxef for Stenotrophomonas maltophilia infection

Hagiya H, Tasaka K, Sendo T, Otsuka F

Infection and Drug Resistance 2015, 8:353-357

Published Date: 20 October 2015

Clinical effectiveness of dolutegravir in the treatment of HIV/AIDS

Taha H, Das A, Das S

Infection and Drug Resistance 2015, 8:339-352

Published Date: 1 October 2015

Modeling human influenza infection in the laboratory

Radigan KA, Misharin AV, Chi M, Scott Budinger GR

Infection and Drug Resistance 2015, 8:311-320

Published Date: 31 August 2015

Impact of the New Delhi metallo-beta-lactamase on beta-lactam antibiotics

Zmarlicka MT, Nailor MD, Nicolau DP

Infection and Drug Resistance 2015, 8:297-309

Published Date: 24 August 2015

Bloodstream infections in intensive care unit patients: distribution and antibiotic resistance of bacteria

Russotto V, Cortegiani A, Graziano G, Saporito L, Raineri SM, Mammina C, Giarratano A

Infection and Drug Resistance 2015, 8:287-296

Published Date: 10 August 2015

Outpatient parenteral antimicrobial therapy with ceftriaxone for acute tonsillopharyngitis: efficacy, patient satisfaction, cost effectiveness, and safety

Al Alawi S, Abdulkarim S, Elhennawy H, Al-Mansoor A, Al Ansari A

Infection and Drug Resistance 2015, 8:279-285

Published Date: 7 August 2015

Prevalence and resistance pattern of Moraxella catarrhalis in community-acquired lower respiratory tract infections

Shaikh SBU, Ahmed Z, Arsalan SA, Shafiq S

Infection and Drug Resistance 2015, 8:263-267

Published Date: 31 July 2015

Profile and microbiological isolates of asymptomatic bacteriuria among pregnant women in Abakaliki, Nigeria

Onu FA, Ajah LO, Ezeonu PO, Umeora OUJ, Ibekwe PC, Ajah MI

Infection and Drug Resistance 2015, 8:231-235

Published Date: 24 July 2015

Clinical predictors for severe sepsis in patients with necrotizing fasciitis: an observational cohort study in northern Thailand

Khamnuan P, Chongruksut W, Jearwattanakanok K, Patumanond J, Tantraworasin A

Infection and Drug Resistance 2015, 8:207-216

Published Date: 16 July 2015

Retrospective analysis of mortality and Candida isolates of 75 patients with candidemia: a single hospital experience

Hirano R, Sakamoto Y, Kudo K, Ohnishi M

Infection and Drug Resistance 2015, 8:199-205

Published Date: 8 July 2015

Profile of oritavancin and its potential in the treatment of acute bacterial skin structure infections

Mitra S, Saeed U, Havlichek DH, Stein GE

Infection and Drug Resistance 2015, 8:189-197

Published Date: 6 July 2015

Efinaconazole in the treatment of onychomycosis

Lipner SR, Scher RK

Infection and Drug Resistance 2015, 8:163-172

Published Date: 1 June 2015

Corynebacterium urealyticum: a comprehensive review of an understated organism

Salem N, Salem L, Saber S, Ismail G, Bluth MH

Infection and Drug Resistance 2015, 8:129-145

Published Date: 21 May 2015

Polymerase chain reaction-based active surveillance of MRSA in emergency department patients

Seki M, Takahashi H, Yamamoto N, Hamaguchi S, Ojima M, Hirose T, Yoshiya K, Ogura H, Shimazu T, Tomono K

Infection and Drug Resistance 2015, 8:113-118

Published Date: 14 May 2015

Validation of a phage-open reading frame typing kit for rapid identification of methicillin-resistant Staphylococcus aureus (MRSA) transmission in a tertiary hospital

Takahashi H, Seki M, Yamamoto N, Hamaguchi S, Ojima M, Hirose T, Yoshiya K, Toyokawa M, Nishi I, Ogura H, Shimazu T, Tomono K

Infection and Drug Resistance 2015, 8:107-111

Published Date: 14 May 2015

blaCTX-M-I group extended spectrum beta lactamase-producing Salmonella typhi from hospitalized patients in Lagos, Nigeria

Akinyemi KO, Iwalokun BA, Alafe OO, Mudashiru SA, Fakorede C

Infection and Drug Resistance 2015, 8:99-106

Published Date: 11 May 2015

Discrepancy in MALDI-TOF MS identification of uncommon Gram-negative bacteria from lower respiratory secretions in patients with cystic fibrosis

AbdulWahab A, Taj-Aldeen SJ, Ibrahim EB, Talaq E, Abu-Madi M, Fotedar R

Infection and Drug Resistance 2015, 8:83-88

Published Date: 30 April 2015

Influence of host resistance on viral adaptation: hepatitis C virus as a case study

Plauzolles A, Lucas M, Gaudieri S

Infection and Drug Resistance 2015, 8:63-74

Published Date: 7 April 2015

Lymphogranuloma venereum: diagnostic and treatment challenges

Ceovic R, Jerkovic Gulin S

Infection and Drug Resistance 2015, 8:39-47

Published Date: 27 March 2015

Evaluation of the appropriateness of imipenem/cilastatin prescription and dosing in a tertiary care hospital

Kabbara WK, Nawas GT, Ramadan WH

Infection and Drug Resistance 2015, 8:31-38

Published Date: 24 March 2015

The role of dolutegravir in the management of HIV infections

Miller MM, Liedtke MD, Lockhart SM, Rathbun RC

Infection and Drug Resistance 2015, 8:19-29

Published Date: 19 February 2015

Wide dissemination of extended-spectrum β-lactamase-producing Escherichia coli in community residents in the Indochinese peninsula

Nakayama T, Ueda S, Huong BTM, Tuyen LD, Komalamisra C, Kusolsuk T, Hirai I, Yamamoto Y

Infection and Drug Resistance 2015, 8:1-5

Published Date: 23 January 2015

Antibiotic lock therapy: review of technique and logistical challenges

Justo JA, Bookstaver PB

Infection and Drug Resistance 2014, 7:343-363

Published Date: 12 December 2014

Current perspectives on the spread of dengue in India

Gupta E, Ballani N

Infection and Drug Resistance 2014, 7:337-342

Published Date: 11 December 2014

Does antimicrobial use density at the ward level influence monthly central line-associated bloodstream infection rates?

Yoshida J, Harada Y, Kikuchi T, Asano I, Ueno T, Matsubara N

Infection and Drug Resistance 2014, 7:331-335

Published Date: 1 December 2014

The effect of a unique propolis compound (PropoelixTM) on clinical outcomes in patients with dengue hemorrhagic fever

Soroy L, Bagus S, Yongkie IP, Djoko W

Infection and Drug Resistance 2014, 7:323-329

Published Date: 9 December 2014

Virulence and antimicrobial resistance of Escherichia coli isolated from Tigris River and children diarrhea

Ibrahim IA, Al-Shwaikh RM, Ismaeil MI

Infection and Drug Resistance 2014, 7:317-322

Published Date: 26 November 2014

Genetic relatedness and host specificity of Pseudomonas aeruginosa isolates from cystic fibrosis and non-cystic fibrosis patients

AbdulWahab A, Taj-Aldeen SJ, Ibrahim E, Abdulla SH, Muhammed R, Ahmed I, Abdeen Y, Sadek O, Abu-Madi M

Infection and Drug Resistance 2014, 7:309-316

Published Date: 20 November 2014

Bacterial bloodstream infections and antimicrobial susceptibility pattern in pediatric hematology/oncology patients after anticancer chemotherapy

Al-Mulla NA, Taj-Aldeen SJ, El Shafie S, Janahi M, Al-Nasser AA, Chandra P

Infection and Drug Resistance 2014, 7:289-299

Published Date: 6 November 2014

An economic model to compare linezolid and vancomycin for the treatment of confirmed methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Germany

Patel DA, Michel A, Stephens J, Weber B, Petrik C, Charbonneau C

Infection and Drug Resistance 2014, 7:273-280

Published Date: 24 October 2014

Optimizing antimicrobial therapy in critically ill patients

Vitrat V, Hautefeuille S, Janssen C, Bougon D, Sirodot M, Pagani L

Infection and Drug Resistance 2014, 7:261-271

Published Date: 20 October 2014

Genotypes and phenotypes of Shiga toxin-producing Escherichia coli (STEC) in Abeokuta, Southwestern Nigeria

Olowe OA, Aboderin BW, Idris OO, Mabayoje VO, Opaleye OO, Adekunle OC, Olowe RA, Akinduti PA, Ojurongbe O

Infection and Drug Resistance 2014, 7:253-259

Published Date: 15 October 2014

Host–pathogen interactions and immune evasion strategies in Francisella tularensis pathogenicity

Steiner DJ, Furuya Y, Metzger DW

Infection and Drug Resistance 2014, 7:239-251

Published Date: 18 September 2014

Moxifloxacin resistance in the F15/LAM4/KZN extensively drug-resistant strain of Mycobacterium tuberculosis

Dookie N, Sturm AW, Moodley P

Infection and Drug Resistance 2014, 7:223-228

Published Date: 19 August 2014

Actinomycosis: etiology, clinical features, diagnosis, treatment, and management

Valour F, Sénéchal A, Dupieux C, Karsenty J, Lustig S, Breton P, Gleizal A, Boussel L, Laurent F, Braun E, Chidiac C, Ader F, Ferry T

Infection and Drug Resistance 2014, 7:183-197

Published Date: 5 July 2014

Safety and feasibility of antibiotic de-escalation in bacteremic pneumonia

Khasawneh FA, Karim A, Mahmood T, Ahmed S, Jaffri SF, Mehmood M

Infection and Drug Resistance 2014, 7:177-182

Published Date: 27 June 2014

Corticosteroids in the treatment of dengue shock syndrome

Rajapakse S, Rodrigo C, Maduranga S, Rajapakse AC

Infection and Drug Resistance 2014, 7:137-143

Published Date: 22 May 2014

Gold mining areas in Suriname: reservoirs of malaria resistance?

Adhin MR, Labadie-Bracho M, Vreden S

Infection and Drug Resistance 2014, 7:111-116

Published Date: 5 May 2014

Long-term efficacy and safety of raltegravir in the management of HIV infection

Liedtke MD, Tomlin CR, Lockhart SM, Miller MM, Rathbun RC

Infection and Drug Resistance 2014, 7:73-84

Published Date: 18 March 2014

Mortality and molecular epidemiology associated with extended-spectrum β-lactamase production in Escherichia coli from bloodstream infection

Leistner R, Sakellariou C, Gürntke S, Kola A, Steinmetz I, Kohler C, Pfeifer Y, Eller C, Gastmeier P, Schwab F

Infection and Drug Resistance 2014, 7:57-62

Published Date: 13 March 2014

Approaches to hepatitis C treatment and cure using NS5A inhibitors

Kohler JJ, Nettles JH, Amblard F, Hurwitz SJ, Bassit L, Stanton RA, Ehteshami M, Schinazi RF

Infection and Drug Resistance 2014, 7:41-56

Published Date: 5 March 2014

Long-term catheterization: current approaches in the diagnosis and treatment of port-related infections

Bustos C, Aguinaga A, Carmona-Torre F, Del Pozo JL

Infection and Drug Resistance 2014, 7:25-35

Published Date: 18 February 2014

Update on otitis media – prevention and treatment

Qureishi A, Lee Y, Belfield K, Birchall JP, Daniel M

Infection and Drug Resistance 2014, 7:15-24

Published Date: 10 January 2014

Limiting and controlling carbapenem-resistant Klebsiella pneumoniae

Saidel-Odes L, Borer A

Infection and Drug Resistance 2014, 7:9-14

Published Date: 10 December 2013

The β-lactamase inhibitor avibactam (NXL104) does not induce ampC β -lactamase in Enterobacter cloacae

Miossec C, Claudon M, Levasseur P, Black MT

Infection and Drug Resistance 2013, 6:235-240

Published Date: 3 December 2013

Antibiotic sensitivity pattern of uropathogens from pregnant women with urinary tract infection in Abakaliki, Nigeria

Onoh RC, Umeora OUJ, Egwuatu VE, Ezeonu PO, Onoh TJP

Infection and Drug Resistance 2013, 6:225-233

Published Date: 2 December 2013

Direct sequencing for rapid detection of multidrug resistant Mycobacterium tuberculosis strains in Morocco

Zakham F, Chaoui I, Echchaoui AH, Chetioui F, Elmessaoudi MD, Ennaji MM, Abid M, El Mzibri M

Infection and Drug Resistance 2013, 6:207-213

Published Date: 28 November 2013

Influenza treatment and prophylaxis with neuraminidase inhibitors: a review

Kamali A, Holodniy M

Infection and Drug Resistance 2013, 6:187-198

Published Date: 19 November 2013

Pseudomonas aeruginosa induces pigment production and enhances virulence in a white phenotypic variant of Staphylococcus aureus

Antonic V, Stojadinovic A, Zhang B, Izadjoo MJ, Alavi M

Infection and Drug Resistance 2013, 6:175-186

Published Date: 6 November 2013

Management strategies in the treatment of neonatal and pediatric gastroenteritis

Ciccarelli S, Stolfi I, Caramia G

Infection and Drug Resistance 2013, 6:133-161

Published Date: 29 October 2013

Communicable disease-related sudden death in the 21st century in Nigeria

Akinwusi PO, Komolafe AO, Olayemi OO, Adeomi AA

Infection and Drug Resistance 2013, 6:125-132

Published Date: 7 October 2013

Whole-genome sequencing in bacteriology: state of the art

Dark MJ

Infection and Drug Resistance 2013, 6:115-123

Published Date: 8 October 2013

The use of platensimycin and platencin to fight antibiotic resistance

Allahverdiyev AM, Bagirova M, Abamor ES, Ates SC, Koc RC, Miraloglu M, Elcicek S, Yaman S, Unal G

Infection and Drug Resistance 2013, 6:99-114

Published Date: 18 September 2013

Risk factors for infections with extended- spectrum beta-lactamase-producing Escherichia coli in a county of Southern Sweden

Tham J, Odenholt I, Walder M, Andersson L, Melander E

Infection and Drug Resistance 2013, 6:93-97

Published Date: 19 September 2013

Phenotypic and molecular characteristics of methicillin-resistant Staphylococcus aureus isolates from Ekiti State, Nigeria

Olowe OA, Kukoyi OO, Taiwo SS, Ojurongbe O, Opaleye OO, Bolaji OS, Adegoke AA, Makanjuola OB, Ogbolu DO, Alli OT

Infection and Drug Resistance 2013, 6:87-92

Published Date: 20 August 2013

Procalcitonin as a useful marker to decide upon intervention for urinary tract infection

Sugimoto K, Shimizu N, Matsumura N, Oki T, Nose K, Nishioka T, Uemura H

Infection and Drug Resistance 2013, 6:83-86

Published Date: 7 August 2013

Streptococcus group C meningitis with cavernous sinus thrombosis

Clarke M, Enuh H, Saverimuttu J, Nfonoyim J

Infection and Drug Resistance 2013, 6:79-81

Published Date: 7 August 2013

Fecal carriage of CTX-M β-lactamase-producing Enterobacteriaceae in nursing homes in the Kinki region of Japan

Luvsansharav UO, Hirai I, Niki M, Nakata A, Yoshinaga A, Yamamoto A, Yamamoto M, Toyoshima H, Kawakami F, Matsuura N, Yamamoto Y

Infection and Drug Resistance 2013, 6:67-70

Published Date: 22 July 2013

Asymptomatic bacteriuria among elderly and middle-aged rural community-dwellers in South-Western Nigeria

Olowe OA, Makanjuola OB, Olabiyi KO, Akinwusi PO, Alebiosu CO, Isawumi MA, Hassan MB, Asekun-Olarinmoye EO, Adebimpe WO, Adewole TA

Infection and Drug Resistance 2013, 6:55-58

Published Date: 9 July 2013

Emerging therapies for Clostridium difficile infection – focus on fidaxomicin

Chaparro-Rojas F, Mullane KM

Infection and Drug Resistance 2013, 6:41-53

Published Date: 28 June 2013

Invasive Aspergillus infections in hospitalized patients with chronic lung disease

Wessolossky M, Welch VL, Sen A, Babu TM, Luke DR

Infection and Drug Resistance 2013, 6:33-39

Published Date: 27 May 2013

Intensive care unit-related fluconazole use in Spain and Germany: patient characteristics and outcomes of a prospective multicenter longitudinal observational study

Wissing H, Ballus J, Bingold TM, Nocea G, Krobot KJ, Kaskel P, Kumar RN, Mavros P

Infection and Drug Resistance 2013, 6:15-25

Published Date: 30 January 2013

Update on the management of chronic rhinosinusitis

Cain RB, Lal D

Infection and Drug Resistance 2013, 6:1-14

Published Date: 23 January 2013

Current management options for latent tuberculosis: a review

Norton BL, Holland DP

Infection and Drug Resistance 2012, 5:163-173

Published Date: 29 November 2012

Adverse incidents resulting in exposure to body fluids at a UK dental teaching hospital over a 6-year period

Hughes A, Davies L, Hale R, Gallagher JE

Infection and Drug Resistance 2012, 5:155-161

Published Date: 25 October 2012

Polypodium leucotomos Extract use to prevent and reduce the risk of infectious diseases in high performance athletes

Marí Solivellas B, Cabanes Martín T

Infection and Drug Resistance 2012, 5:149-153

Published Date: 16 October 2012

Prevalence of extended-spectrum beta-lactamase-producing bacteria in food

Tham J, Walder M, Melander E, Odenholt I

Infection and Drug Resistance 2012, 5:143-147

Published Date: 16 October 2012

Overview of the epidemiology and the threat of Klebsiella pneumoniae carbapenemases (KPC) resistance

Chen LF, Anderson DJ, Paterson DL

Infection and Drug Resistance 2012, 5:133-141

Published Date: 24 September 2012

Development of ceftazidime resistance in an acute Burkholderia pseudomallei infection

Sarovich DS, Price EP, Limmathurotsakul D, Cook JM, Von Schulze AT, Wolken SR, Keim P, Peacock SJ, Pearson T

Infection and Drug Resistance 2012, 5:129-132

Published Date: 22 August 2012

Treatment of dengue fever

Rajapakse S, Rodrigo C, Rajapakse A

Infection and Drug Resistance 2012, 5:103-112

Published Date: 23 July 2012

Prospective evaluation of simply modified MODS assay: an effective tool for TB diagnosis and detection of MDR-TB

Chaiyasirinroje B, Aung MN, Moolphate S, Kasetjaroen Y, Rienthong S, Rienthong D, Nampaisan O, Nedsuwan S, Sangchun W, Suriyon N, Mitarai S, Yamada N

Infection and Drug Resistance 2012, 5:79-86

Published Date: 7 May 2012

The effects of daily chlorhexidine bathing on cutaneous bacterial isolates: a pilot study

Soma VL, Qin X, Zhou C, Adler A, Berry JE, Zerr DM

Infection and Drug Resistance 2012, 5:75-78

Published Date: 24 April 2012

High prevalence of extended-spectrum β-lactamase-producing pathogens: results of a surveillance study in two hospitals in Ujjain, India

Pathak A, Marothi Y, Kekre V, Mahadik K, Macaden R, Stålsby Lundborg C

Infection and Drug Resistance 2012, 5:65-73

Published Date: 5 April 2012

Comparative efficacy of uncontrolled and controlled intermittent preventive treatment during pregnancy (IPTp) with combined use of LLTNs in high resistance area to sulfadoxine-pyrimethamine in Côte d’Ivoire

Offianan AT, Penali LK, Coulibaly MA, Tiacoh NL, Ako AAB, Adji EG, Coulibaly B, Koffi D, Sarr D, Jambou R, Kone M

Infection and Drug Resistance 2012, 5:53-63

Published Date: 12 March 2012

Clinical evaluation of the role of ceftaroline in the management of community acquired bacterial pneumonia

Maselli DJ, Fernandez JF, Whong CY, Echevarria K, Nambiar AM, Anzueto A, Restrepo MI

Infection and Drug Resistance 2012, 5:43-51

Published Date: 1 February 2012

Conjunctival sac bacterial flora isolated prior to cataract surgery

Suto C, Morinaga M, Yagi T, Tsuji C, Toshida H

Infection and Drug Resistance 2012, 5:37-41

Published Date: 24 January 2012

Ceftaroline in complicated skin and skin-structure infections

Hernandez PO, Lema S, Tyring SK, Mendoza N

Infection and Drug Resistance 2012, 5:23-35

Published Date: 19 January 2012

Evaluation of the use of piperacillin/tazobactam (Tazocin®) at Hamad General Hospital, Qatar: are there unjustified prescriptions?

Khan FY, Elhiday A, Khudair IF, Yousef H, Omran AH, Alsamman SH, Elhamid M

Infection and Drug Resistance 2012, 5:17-21

Published Date: 13 January 2012

A necrotic lung ball caused by co-infection with Candida and Streptococcus pneumoniae

Yokoyama T, Sasaki J, Matsumoto K, Koga C, Ito Y, Kaku Y, Tajiri M, Natori H, Hirokawa M

Infection and Drug Resistance 2011, 4:221-224

Published Date: 15 December 2011

Resistance to antimicrobial drugs in Ghana

Newman MJ, Frimpong E, Donkor ES, Opintan JA, Asamoah-Adu A

Infection and Drug Resistance 2011, 4:215-220

Published Date: 21 December 2011

An Enterobacter plasmid as a new genetic background for the transposon Tn1331

Alavi MR, Antonic V, Ravizee A, Weina PJ, Izadjoo M, Stojadinovic A

Infection and Drug Resistance 2011, 4:209-213

Published Date: 28 November 2011

Acceptance of a pandemic influenza vaccine: a systematic review of surveys of the general public

Nguyen T, Holdt Henningsen K, Brehaut JC, Hoe E, Wilson K

Infection and Drug Resistance 2011, 4:197-207

Published Date: 20 October 2011

Effect of long-term treatment with eyedrops for glaucoma on conjunctival bacterial flora

Honda R, Toshida H, Suto C, Fujimaki T, Kimura T, Ohta T, Murakami A

Infection and Drug Resistance 2011, 4:191-196

Published Date: 20 October 2011

Demographic features and antibiotic resistance among children hospitalized for urinary tract infection in northwest Iran

Ghorashi Z, Ghorashi S, Soltani-Ahari H, Nezami N

Infection and Drug Resistance 2011, 4:171-176

Published Date: 11 October 2011

Meningococcal conjugate vaccines: optimizing global impact

Terranella A, Cohn A, Clark T

Infection and Drug Resistance 2011, 4:161-169

Published Date: 21 September 2011

Review of oral cholera vaccines: efficacy in young children

Masuet Aumatell C, Ramon Torrell JM, Zuckerman JN

Infection and Drug Resistance 2011, 4:155-160

Published Date: 14 September 2011

Impact of restriction of cefepime use on the antimicrobial susceptibility of Gram-negative bacilli related to healthcare-associated infections in an orthopedic hospital

Oliveira PR, Paula AP, Dal-Paz K, Felix CS, Rossi F, Silva JS, Lima ALM

Infection and Drug Resistance 2011, 4:149-154

Published Date: 4 August 2011

Treatment of drug-resistant tuberculosis

Pinto LM, Menzies D

Infection and Drug Resistance 2011, 4:129-135

Published Date: 21 July 2011

Evaluation of in-vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferi

Sapi E, Kaur N, Anyanwu S, Luecke DF, Datar A, Patel S, Rossi M, Stricker RB

Infection and Drug Resistance 2011, 4:97-113

Published Date: 3 May 2011

Telavancin, a new lipoglycopeptide antimicrobial, in complicated skin and soft tissue infections

Lida Jafari Saraf, Samuel Eric Wilson

Infection and Drug Resistance 2011, 4:87-95

Published Date: 10 March 2011

Potential role of tigecycline in the treatment of community-acquired bacterial pneumonia

Mary L Townsend, Melanie W Pound, Richard H Drew

Infection and Drug Resistance 2011, 4:77-86

Published Date: 2 March 2011

Patterns of resistance development with integrase inhibitors in HIV

Jean L Mbisa, Supang A Martin, Patricia A Cane

Infection and Drug Resistance 2011, 4:65-76

Published Date: 22 February 2011

Update on the optimal use of voriconazole for invasive fungal infections

Asma Lat George R Thompson III

Infection and Drug Resistance 2011, 4:43-53

Published Date: 3 February 2011

Management of refractory Pseudomonas aeruginosa infection in cystic fibrosis

Roger Sordé, Albert Pahissa, Jordi Rello

Infection and Drug Resistance 2011, 4:31-41

Published Date: 25 January 2011

Management of Chlamydia trachomatis genital tract infection: screening and treatment challenges

Brandie D Taylor, Catherine L Haggerty

Infection and Drug Resistance 2011, 4:19-29

Published Date: 20 January 2011

Current treatment of choice for chronic hepatitis C infection

Tareq Yasin, Thomas R Riley, Ian R Schreibman

Infection and Drug Resistance 2011, 4:11-18

Published Date: 12 January 2011

Lyme disease: the next decade

Raphael B Stricker, Lorraine Johnson

Infection and Drug Resistance 2011, 4:1-9

Published Date: 7 January 2011

Current strategies for the prevention and management of central line-associated bloodstream infections

Zhuolin Han, Stephen Y Liang, Jonas Marschall

Infection and Drug Resistance 2010, 3:147-163

Published Date: 23 November 2010

Clinical perspective on aztreonam lysine for inhalation in patients with cystic fibrosis

Martha K Daddario, Jennifer K Hagerman, Michael E Klepser

Infection and Drug Resistance 2010, 3:123-132

Published Date: 28 October 2010

Multidrug and extensively drug-resistant tuberculosis from a general practice perspective

BM Yashodhara, Choo Beng Huat, Lakshmi Nagappa Naik, et al

Infection and Drug Resistance 2010, 3:115-122

Published Date: 22 October 2010

Extended use of raltegravir in the treatment of HIV-1 infection: optimizing therapy

Charlotte Charpentier, Laurence Weiss

Infection and Drug Resistance 2010, 3:103-114

Published Date: 13 October 2010

Daptomycin: a novel lipopeptide antibiotic against Gram-positive pathogens

Andres Beiras-Fernandez, Ferdinand Vogt, Ralf Sodian, et al.

Infection and Drug Resistance 2010, 3:95-101

Published Date: 30 August 2010

Acquired resistance of malarial parasites against artemisinin-based drugs: social and economic impacts

Johanna M Porter-Kelley, Joann Cofie, Sophonie Jean, et al

Infection and Drug Resistance 2010, 3:87-94

Published Date: 19 August 2010

Methicillin-resistant Staphylococcus aureus in HIV-infected patients

Alicia I Hidron, Russell Kempker, Abeer Moanna, et al

Infection and Drug Resistance 2010, 3:73-86

Published Date: 6 August 2010

The use of anti-tuberculosis therapy for latent TB infection

Justin T Denholm, Emma S McBryde

Infection and Drug Resistance 2010, 3:63-72

Published Date: 21 July 2010

Role of posaconazole in the treatment of oropharyngeal candidiasis

Voichita Ianas, Kathryn R Matthias, Stephen A Klotz

Infection and Drug Resistance 2010, 3:45-51

Published Date: 28 June 2010

Drug resistance in community-acquired respiratory tract infections: role for an emerging antibacterial

Lorenzo Aguilar, María-José Giménez, José Barberán

Infection and Drug Resistance 2010, 3:35-43

Published Date: 18 June 2010

Emerging agents to combat complicated and resistant infections: focus on ceftobiprole

César Bustos, Jose L Del Pozo

Infection and Drug Resistance 2010, 3:5-14

Published Date: 22 April 2010

Respiratory failure caused by intrathoracic amoebiasis

Toshinobu Yokoyama, Masashi Hirokawa, Yutaka Imamura, et al

Infection and Drug Resistance 2010, 3:1-4

Published Date: 11 March 2010

Anidulafungin and its role in candida infections

Diane M Cappelletty, Rose Jung

Infection and Drug Resistance 2009, 2:51-60

Published Date: 30 June 2009

Doripenem in hospital infections: a focus on nosocomial pneumonia, complicated intra-abdominal infections, and complicated urinary tract infections

Tze Shien Lo, Stephanie M Borchardt, Justin M Welch, Melissa A Rohrich, Augusto M Alonto, Anne V Alonto

Infection and Drug Resistance 2009, 2:41-49

Published Date: 30 June 2009

Evidence based approach to the treatment of community-associated methicillin-resistant Staphylococcus aureus

William J Peppard, Anne Daniels, Lynne Fehrenbacher, Jamie Winner

Infection and Drug Resistance 2009, 2:27-40

Published Date: 8 June 2009

New approaches in the management of chronic hepatitis B: role of tenofovir

Jurriën GP Reijnders, Harry LA Janssen

Infection and Drug Resistance 2009, 2:13-26

Published Date: 24 April 2009

The determinants of the antibiotic resistance process

Beatriz Espinosa Franco, Marina Altagracia Martínez, Martha A Sánchez Rodríguez, Albert I Wertheimer

Infection and Drug Resistance 2009, 2:1-11

Published Date: 17 April 2009

Micafungin in the treatment of invasive candidiasis and invasive aspergillosis

Nathan P Wiederhold, Jason M Cota, Christopher R Frei

Infection and Drug Resistance 2008, 1:63-77

Published Date: 12 January 2009

High prevalence of multidrug-resistant MRSA in a tertiary care hospital of northern India

Hare Krishna Tiwari, Darshan Sapkota, Malaya Ranjan Sen

Infection and Drug Resistance 2008, 1:57-61

Published Date: 30 November 2008

Expression of the MexXY-OprM efflux system in Pseudomonas aeruginosa with discordant cefepime/ceftazidime susceptibility profiles

Somvadee Laohavaleeson, Karen Lolans, John P Quinn, Joseph L Kuti, David P Nicolau

Infection and Drug Resistance 2008, 1:51-55

Published Date: 23 November 2008

Characterization and antibiotic susceptibility of Listeria monocytogenes isolated from poultry and red meat in Morocco

Hayat Ennaji, Mohammed Timinouni, My Mustapha Ennaji, Mohammed Hassar, Nozha Cohen

Infection and Drug Resistance 2008, 1:45-50

Published Date: 28 September 2008

Current and novel antibiotics against resistant Gram-positive bacteria

Federico Perez, Robert A Salata, Robert A Bonomo

Infection and Drug Resistance 2008, 1:27-44

Published Date: 9 September 2008

New simple decontamination method improves microscopic detection and culture of mycobacteria in clinical practice

Nora Morcillo, Belén Imperiale, Juan Carlos Palomino

Infection and Drug Resistance 2008, 1:21-26

Published Date: 20 August 2008

Procalcitonin implication in renal cell apoptosis induced by acute pyelonephritis in children

Hafid Belhadj-Tahar, Yvon Coulais, Mathieu Tafani, François Bouissou

Infection and Drug Resistance 2008, 1:17-20

Published Date: 12 August 2008

Pilonidal sinus of the penis

H Al Chalabi, H A Ghalib, M Nabri, T O’Hanrahan

Infection and Drug Resistance 2008, 1:13-15

Published Date: 6 August 2008

Successful treatment of a neonate with persistent vancomycin-resistant enterococcal bacteremia with a daptomycin-containing regimen

Christy A Beneri, David P Nicolau, Howard S Seiden, Lorry G Rubin

Infection and Drug Resistance 2008, 1:9-11

Published Date: 12 August 2008

Deep neck abscess: an analysis of microbial etiology and the effectiveness of antibiotics

Shih-Wei Yang, Ming-Hsun Lee, Lai-Chu See, Shu-Huan Huang, Tsung-Ming Chen, Tai-An Chen

Infection and Drug Resistance 2008, 1:1-8

Published Date: 7 July 2008